{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:13:45Z","timestamp":1790615625879,"version":"4.1.0"},"reference-count":97,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T00:00:00Z","timestamp":1539648000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.02239","type":"journal-article","created":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T00:57:40Z","timestamp":1539651460000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":76,"title":["Clinical and Genetic Heterogeneity of CARD14 Mutations in Psoriatic Skin Disease"],"prefix":"10.3389","volume":"9","author":[{"given":"Laura","family":"Israel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Mellett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,10,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/cr.2010.182","article-title":"NF-\u03baB signaling pathways regulated by CARMA family of scaffold proteins","volume":"21","author":"Blonska","year":"2011","journal-title":"Cell Res"},{"key":"B2","doi-asserted-by":"publisher","first-page":"914","DOI":"10.15252\/embr.201642109","article-title":"The paracaspase MALT1 mediates CARD14-induced signaling in keratinocytes","volume":"17","author":"Afonina","year":"2016","journal-title":"EMBO Rep"},{"key":"B3","doi-asserted-by":"publisher","first-page":"11877","DOI":"10.1074\/jbc.M010512200","article-title":"CARD11 and CARD14 are novel caspase recruitment domain (CARD)\/membrane-associated guanylate kinase (MAGUK) family members that interact with BCL10 and activate NF-\u03baB","volume":"276","author":"Bertin","year":"2001","journal-title":"J Biol Chem"},{"key":"B4","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1002\/jcp.22667","article-title":"Alternative splicing of CARMA2\/CARD14 transcripts generates protein variants with differential effect on NF-kappaB activation and endoplasmic reticulum stress-induced cell death","volume":"226","author":"Scudiero","year":"2011","journal-title":"J Cell Physiol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e111255","DOI":"10.1371\/journal.pone.0111255","article-title":"CARD14 expression in dermal endothelial cells in psoriasis","volume":"9","author":"Harden","year":"2014","journal-title":"PLoS ONE"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1016\/j.jid.2018.03.1503","article-title":"A CARD10-dependent tonic signalosome activates MALT1 paracaspase and regulates IL-17\/TNF-alpha driven keratinocyte inflammation","volume":"138","author":"Israel","year":"2018","journal-title":"J Invest Dermatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1002\/jcp.24543","article-title":"The three CARMA sisters: so different, so similar: a portrait of the three CARMA proteins and their involvement in human disorders","volume":"229","author":"Scudiero","year":"2014","journal-title":"J Cell Physiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.jaci.2015.06.031","article-title":"Genetic errors of the human caspase recruitment domain-B-cell lymphoma 10-mucosa-associated lymphoid tissue lymphoma-translocation gene 1 (CBM) complex: molecular, immunologic, and clinical heterogeneity","volume":"136","author":"Perez","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.ajhg.2012.03.012","article-title":"PSORS2 is due to mutations in CARD14","volume":"90","author":"Jordan","year":"2012","journal-title":"Am J Hum Genet"},{"key":"B10","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.ajhg.2012.03.013","article-title":"Rare and common variants in CARD14, encoding an epidermal regulator of NF-\u03baB, in psoriasis","volume":"90","author":"Jordan","year":"2012","journal-title":"Am J Hum Genet"},{"key":"B11","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1086\/377159","article-title":"The International Psoriasis Genetics Study: assessing linkage to 14 candidate susceptibility loci in a cohort of 942 affected sib pairs","volume":"73","author":"International","year":"2003","journal-title":"Am J Hum Genet"},{"key":"B12","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ajhg.2012.05.010","article-title":"Familial pityriasis rubra pilaris is caused by mutations in CARD14","volume":"91","author":"Fuchs-Telem","year":"2012","journal-title":"Am J Hum Genet"},{"key":"B13","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1046\/j.1365-2230.2001.00832.x","article-title":"Psoriasis\u2013epidemiology and clinical spectrum","volume":"26","author":"Christophers","year":"2001","journal-title":"Clin Exp Dermatol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"J314","DOI":"10.1016\/j.jaut.2009.12.001","article-title":"Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis","volume":"34","author":"Chandran","year":"2010","journal-title":"J Autoimmun"},{"key":"B15","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1056\/NEJMra0804595","article-title":"Psoriasis","volume":"361","author":"Nestle","year":"2009","journal-title":"N Engl J Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/bjd.12631","article-title":"Bimodal immune activation in psoriasis","volume":"170","author":"Christophers","year":"2014","journal-title":"Br J Dermatol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/j.1365-2133.2006.07675.x","article-title":"A classification of psoriasis vulgaris according to phenotype","volume":"156","author":"Griffiths","year":"2007","journal-title":"Br J Dermatol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0140-6736(07)61128-3.","article-title":"Pathogenesis and clinical features of psoriasis","volume":"370","author":"Griffiths","year":"2007","journal-title":"Lancet"},{"key":"B19","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/0190-9622(95)91336-X","article-title":"Disease concomitance in psoriasis","volume":"32","author":"Henseler","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.jaad.2006.08.040","article-title":"Prevalence of cardiovascular risk factors in patients with psoriasis","volume":"55","author":"Neimann","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00403-006-0703-z","article-title":"Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis","volume":"298","author":"Sommer","year":"2006","journal-title":"Arch Dermatol Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.jaad.2013.07.023","article-title":"Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European\/North American dermatology clinics","volume":"69","author":"Mease","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/exd.13467","article-title":"Interleukin-17 alters the biology of many cell types involved in the genesis of psoriasis, systemic inflammation and associated comorbidities","volume":"27","author":"Krueger","year":"2018","journal-title":"Exp Dermatol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1038\/jid.2012.184","article-title":"Expanding the psoriasis disease profile: interrogation of the skin and serum of patients with moderate-to-severe psoriasis","volume":"132","author":"Suarez-Farinas","year":"2012","journal-title":"J Invest Dermatol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1155\/MI.2005.273","article-title":"Serum levels of TNF-alpha IFN-gamma IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity","volume":"2005","author":"Arican","year":"2005","journal-title":"Mediators Inflamm"},{"key":"B26","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/bjd.16232","article-title":"Pustular psoriasis and related pustular skin diseases","volume":"178","author":"Bachelez","year":"2018","journal-title":"Br J Dermatol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1056\/NEJMoa1013068","article-title":"Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis","volume":"365","author":"Marrakchi","year":"2011","journal-title":"N Engl J Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.ajhg.2011.07.022","article-title":"Mutations in IL36RN\/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis","volume":"89","author":"Onoufriadis","year":"2011","journal-title":"Am J Hum Genet"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1038\/jid.2013.230","article-title":"The majority of generalized pustular psoriasis without psoriasis vulgaris is caused by deficiency of interleukin-36 receptor antagonist","volume":"133","author":"Sugiura","year":"2013","journal-title":"J Invest Dermatol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.ajhg.2014.04.005","article-title":"AP1S3 mutations are associated with pustular psoriasis and impaired Toll-like receptor 3 trafficking","volume":"94","author":"Setta-Kaffetzi","year":"2014","journal-title":"Am J Hum Genet"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1016\/j.jid.2016.06.618","article-title":"AP1S3 Mutations cause skin autoinflammation by disrupting keratinocyte autophagy and Up-Regulating IL-36 production","volume":"136","author":"Mahil","year":"2016","journal-title":"J Invest Dermatol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"E2526","DOI":"10.3390\/ijms18122526","article-title":"The genetic basis of psoriasis","volume":"18","author":"Capon","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1126\/science.8178173","article-title":"Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q","volume":"264","author":"Tomfohrde","year":"1994","journal-title":"Science"},{"key":"B34","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1136\/jmg.2004.018564","article-title":"Mapping of psoriasis to 17q terminus","volume":"42","author":"Hwu","year":"2005","journal-title":"J Med Genet"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1093\/hmg\/6.8.1349","article-title":"Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan","volume":"6","author":"Nair","year":"1997","journal-title":"Hum Mol Genet"},{"key":"B36","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/bjd.12050","article-title":"Genome-wide linkage scan for psoriasis susceptibility loci in multiplex Tunisian families","volume":"168","author":"Ammar","year":"2013","journal-title":"Br J Dermatol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/bjd.14158","article-title":"CARD14 alterations in Tunisian patients with psoriasis and further characterization in European cohorts","volume":"174","author":"Ammar","year":"2016","journal-title":"Br J Dermatol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1038\/jid.2015.288","article-title":"Activating CARD14 mutations are associated with generalized pustular psoriasis but rarely account for familial recurrence in psoriasis vulgaris","volume":"135","author":"Berki","year":"2015","journal-title":"J Invest Dermatol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.jaad.2018.02.034","article-title":"CARD14-associated papulosquamous eruption: a spectrum including features of psoriasis and pityriasis rubra pilaris","volume":"79","author":"Craiglow","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"885","DOI":"10.2340\/00015555-2405","article-title":"Intra-familial variation in clinical phenotype of CARD14-related Psoriasis","volume":"96","author":"Eskin-Schwartz","year":"2016","journal-title":"Acta Derm Venereol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1038\/jid.2015.186","article-title":"Palmoplantar pustular psoriasis is associated with missense variants in CARD14, but not with loss-of-function mutations in IL36RN in European patients","volume":"135","author":"Mossner","year":"2015","journal-title":"J Invest Dermatol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15029","article-title":"Immune-regulatory genes as possible modifiers of familial pityriasis rubra pilaris-Lessons from a family with PRP and psoriasis","author":"Spoerri","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1093\/rheumatology\/keu419","article-title":"Childhood-onset PsA in Down syndrome with psoriasis susceptibility variant CARD14 rs11652075","volume":"54","author":"Sugiura","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1038\/jid.2014.46","article-title":"CARD14 c","volume":"134","author":"Sugiura","year":"2014","journal-title":"J Invest Dermatol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1111\/bjd.15442","article-title":"Autosomal dominant familial generalized pustular psoriasis caused by a CARD14 mutation","volume":"177","author":"Takeichi","year":"2017","journal-title":"Br J Dermatol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/1346-8138.13065","article-title":"CARD14 gene polymorphism c","volume":"43","author":"Feng","year":"2016","journal-title":"J Dermatol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1089\/dna.2013.2109","article-title":"SNP rs11652075 in the CARD14 gene as a risk factor for psoriasis (PSORS2) in a Spanish cohort","volume":"32","author":"Gonzalez-Lara","year":"2013","journal-title":"DNA Cell Biol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/bjd.14461","article-title":"Common and rare CARD14 gene variants affect the antitumour necrosis factor response among patients with psoriasis","volume":"175","author":"Coto-Segura","year":"2016","journal-title":"Br J Dermatol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1038\/jid.2014.269","article-title":"Variant analysis of CARD14 in a Chinese Han population with psoriasis vulgaris and generalized pustular psoriasis","volume":"134","author":"Qin","year":"2014","journal-title":"J Invest Dermatol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.4238\/gmr.15038357","article-title":"The common CARD14 gene missense polymorphism rs11652075 (c","author":"Shi","year":"2016","journal-title":"Genet Mol Res"},{"key":"B51","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1590\/abd1806-4841.20164016","article-title":"Variants of CARD14 gene and psoriasis vulgaris in southern Chinese cohort","volume":"91","author":"Zhu","year":"2016","journal-title":"An Bras Dermatol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"587","DOI":"10.2340\/00015555-1814","article-title":"Genetic analysis of CARD14 in non-familial pityriasis rubra pilaris: a case series","volume":"94","author":"Hong","year":"2014","journal-title":"Acta Derm Venereol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"8240","DOI":"10.1021\/bi101052d","article-title":"Oncogenic CARD11 mutations induce hyperactive signaling by disrupting autoinhibition by the PKC-responsive inhibitory domain","volume":"49","author":"Lamason","year":"2010","journal-title":"Biochemistry"},{"key":"B54","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.det.2014.09.006","article-title":"An update on topical therapies for mild-moderate psoriasis","volume":"33","author":"van de Kerkhof","year":"2015","journal-title":"Dermatol Clin"},{"key":"B55","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1177\/1759720X17735756","article-title":"Anti-interleukin and interleukin therapies for psoriasis: current evidence and clinical usefulness","volume":"9","author":"Tsai","year":"2017","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"B56","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1001\/jamadermatol.2016.3601","article-title":"Pityriasis Rubra Pilaris Type V as an Autoinflammatory Disease by CARD14 Mutations","volume":"153","author":"Takeichi","year":"2017","journal-title":"JAMA Dermatol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1111\/bjd.12799","article-title":"Increased epidermal expression and absence of mutations in CARD14 in a series of patients with sporadic pityriasis rubra pilaris","volume":"170","author":"Eytan","year":"2014","journal-title":"Br J Dermatol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"989","DOI":"10.2340\/00015555-2446","article-title":"Target-sequence Capture and High Throughput Sequencing Identify a De novo CARD14 Mutation in an Infant with Erythrodermic Pityriasis Rubra Pilaris","volume":"96","author":"Has","year":"2016","journal-title":"Acta Derm Venereol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/1346-8138.13008","article-title":"CARD14 Glu138 mutation in familial pityriasis rubra pilaris does not warrant differentiation from familial psoriasis","volume":"43","author":"Inoue","year":"2016","journal-title":"J Dermatol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1038\/jid.2015.65","article-title":"Analysis of CARD14 Polymorphisms in pityriasis rubra pilaris: activation of NF-\u03baB","volume":"135","author":"Li","year":"2015","journal-title":"J Invest Dermatol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1111\/bjd.15462","article-title":"Beneficial effect of ustekinumab in familial pityriasis rubra pilaris with a new missense mutation in CARD14","volume":"178","author":"Lwin","year":"2018","journal-title":"Br J Dermatol"},{"key":"B62","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2230.1980.tb01676.x","article-title":"Pityriasis rubra pilaris","volume":"5","author":"Griffiths","year":"1980","journal-title":"Clin Exp Dermatol"},{"key":"B63","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/00000372-198608000-00001","article-title":"Histologic criteria for the diagnosis of pityriasis rubra pilaris","volume":"8","author":"Soeprono","year":"1986","journal-title":"Am J Dermatopathol"},{"key":"B64","first-page":"844","article-title":"Familial pityriasis rubra pilaris: report of a family and therapeutic response to etanercept","volume":"9","author":"Vasher","year":"2010","journal-title":"J Drugs Dermatol"},{"key":"B65","first-page":"271","article-title":"Acute juvenile pityriasis rubra pilaris: a case report after mononucleosis infection","volume":"143","author":"Betto","year":"2008","journal-title":"G Ital Dermatol Venereol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1046\/j.1525-1470.2002.00236_5.x","article-title":"Further clinical evidence for involvement of bacterial superantigens in juvenile pityriasis rubra pilaris (PRP): report of two new cases","volume":"19","author":"Mohrenschlager","year":"2002","journal-title":"Pediatr Dermatol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1159\/000240018","article-title":"Pityriasis rubra pilaris with preceding cytomegalovirus infection","volume":"219","author":"Kawara","year":"2009","journal-title":"Dermatology"},{"key":"B68","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1111\/j.1365-2133.1995.tb06939.x","article-title":"Pityriasis rubra pilaris and human immunodeficiency virus infection","volume":"133","author":"Miralles","year":"1995","journal-title":"Br J Dermatol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(08)80734-7","article-title":"Pityriasis rubra pilaris in a patient with human immunodeficiency virus infection","author":"Auffret","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1001\/jamadermatol.2016.0091","article-title":"Epidemiologic clinicopathologic diagnostic, and management challenges of pityriasis rubra pilaris: a case series of 100 patients","volume":"152","author":"Ross","year":"2016","journal-title":"JAMA Dermatol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1042\/BCJ20160270","article-title":"Psoriasis mutations disrupt CARD14 autoinhibition promoting BCL10-MALT1-dependent NF-\u03baB activation","volume":"473","author":"Howes","year":"2016","journal-title":"Biochem J"},{"key":"B72","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1016\/j.jid.2018.03.1525","article-title":"CARD14 gain-of-function mutation alone is sufficient to drive IL-23\/IL-17-mediated psoriasiform skin inflammation in vivo","volume":"138","author":"Mellett","year":"2018","journal-title":"J Invest Dermatol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"e2627","DOI":"10.1038\/cddis.2017.51","article-title":"CARMA2sh and ULK2 control pathogen-associated molecular patterns recognition in human keratinocytes: psoriasis-linked CARMA2sh mutants escape ULK2 censorship","volume":"8","author":"Scudiero","year":"2017","journal-title":"Cell Death Dis"},{"key":"B74","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1111\/j.1365-2133.2010.09855.x","article-title":"Treatment of pityriasis rubra pilaris with ustekinumab","volume":"163","author":"Wohlrab","year":"2010","journal-title":"Br J Dermatol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1016\/j.jaad.2008.05.037","article-title":"Infliximab monotherapy as first-line treatment for adult-onset pityriasis rubra pilaris: case report and review of the literature on biologic therapy","volume":"59","author":"Muller","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1111\/bjd.15867","article-title":"The genetic basis for most patients with pustular skin disease remains elusive","volume":"178","author":"Mossner","year":"2018","journal-title":"Br J Dermatol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.det.2014.09.001","article-title":"Genetics of psoriasis","volume":"33","author":"Mahil","year":"2015","journal-title":"Dermatol Clin"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1086\/302932","article-title":"Localization of psoriasis-susceptibility locus PSORS1 to a 60-kb interval telomeric to HLA-C","volume":"66","author":"Nair","year":"2000","journal-title":"Am J Hum Genet"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1046\/j.1365-2133.2000.03885.x","article-title":"HLA-C and guttate psoriasis","volume":"143","author":"Mallon","year":"2000","journal-title":"Br J Dermatol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.molcel.2013.08.032","article-title":"Structural architecture of the CARMA1\/Bcl10\/MALT1 signalosome: nucleation-induced filamentous assembly","volume":"51","author":"Qiao","year":"2013","journal-title":"Mol Cell"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.3389\/fimmu.2018.01564","article-title":"Nuclear factor \u03baB activation in a Type V pityriasis rubra pilaris patient harboring multiple CARD14 variants","volume":"9","author":"Danis","year":"2018","journal-title":"Front Immunol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.immuni.2018.05.012","article-title":"Gain-of-function mutation of Card14 leads to spontaneous psoriasis-like skin inflammation through enhanced keratinocyte response to IL-17A","volume":"49","author":"Wang","year":"2018","journal-title":"Immunity"},{"key":"B83","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/ng.2007.48","article-title":"Psoriasis is associated with increased beta-defensin genomic copy number","volume":"40","author":"Hollox","year":"2008","journal-title":"Nat Genet"},{"key":"B84","doi-asserted-by":"publisher","first-page":"71","DOI":"10.4049\/jimmunol.1700995","article-title":"Essential role of CARD14 in murine experimental psoriasis","volume":"200","author":"Tanaka","year":"2018","journal-title":"J Immunol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis","volume":"182","author":"van der Fits","year":"2009","journal-title":"J Immunol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1084\/jem.20050500","article-title":"Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production","volume":"202","author":"Nestle","year":"2005","journal-title":"J Exp Med"},{"key":"B87","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s13555-017-0187-0","article-title":"Guselkumab for the Treatment of psoriasis: a review of phase III trials","volume":"7","author":"Nakamura","year":"2017","journal-title":"Dermatol Ther (Heidelb)"},{"key":"B88","doi-asserted-by":"publisher","first-page":"Ab164","DOI":"10.1016\/j.jaad.2017.04.637","article-title":"Maintenance of treatment response in chronic plaque psoriasis patients continuing treatment or discontinuing treatment with tildrakizumab in a 64-week, randomized controlled, phase 3 trial","volume":"76","author":"Papp","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/S0140-6736(17)31279-5","article-title":"Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials","volume":"390","author":"Reich","year":"2017","journal-title":"Lancet"},{"key":"B90","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1111\/ajd.12669","article-title":"Acute generalized exanthematous pustulosis and polyarthritis associated with a novel CARD14 mutation","volume":"59","author":"Podlipnik","year":"2017","journal-title":"Australas J Dermatol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.jaad.2015.07.017","article-title":"Acute generalized exanthematous pustulosis (AGEP): a review and update","volume":"73","author":"Szatkowski","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1038\/jid.2013.44","article-title":"Rare variations in IL36RN in severe adverse drug reactions manifesting as acute generalized exanthematous pustulosis","volume":"133","author":"Navarini","year":"2013","journal-title":"J Invest Dermatol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.jid.2015.12.027","article-title":"MALT1 protease activity controls the expression of inflammatory genes in keratinocytes upon zymosan stimulation","volume":"136","author":"Schmitt","year":"2016","journal-title":"J Invest Dermatol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"25880","DOI":"10.1074\/jbc.C110.109421","article-title":"The CARMA3-Bcl10-MALT1 signalosome promotes angiotensin II-dependent vascular inflammation and atherogenesis","volume":"285","author":"McAllister-Lucas","year":"2010","journal-title":"J Biol Chem"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1111\/jdv.14386","article-title":"European consensus statement on phenotypes of pustular psoriasis","volume":"31","author":"Navarini","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/j.jaci.2017.05.019","article-title":"Autoinflammatory keratinization diseases","volume":"140","author":"Akiyama","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jdermsci.2018.01.012","article-title":"Autoinflammatory keratinization diseases: an emerging concept encompassing various inflammatory keratinization disorders of the skin","volume":"90","author":"Akiyama","year":"2018","journal-title":"J Dermatol Sci"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02239\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T00:57:43Z","timestamp":1539651463000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02239\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,16]]},"references-count":97,"alternative-id":["10.3389\/fimmu.2018.02239"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.02239","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,16]]},"article-number":"2239"}}